Online Inquiry

Biotin-PEG-Biotin, MW 600-35k

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category Biotin PEG
Catalog NO. BPG-1282
Product Name Biotin-PEG-Biotin, MW 600-35k
Molecular Formula C26H44N6O6S2
Molecular Weight Customizable
Biotin-PEG-Biotin, MW 600-35k
  • Scheme Design
  • Custom Synthesis
  • cGMP Manufacturing
  • Quality Assurance

Fast track to get specific molecular weight products:

CatalogMolecular WeightAvailability
BPG-1282-1 Biotin-PEG-Biotin, MW 600 In stock Inquiry
BPG-1282-2 Biotin-PEG-Biotin, MW 1k In stock Inquiry
BPG-1282-3 Biotin-PEG-Biotin, MW 2k In stock Inquiry
BPG-1282-4 Biotin-PEG-Biotin, MW 3.4k In stock Inquiry
BPG-1282-5 Biotin-PEG-Biotin, MW 5k In stock Inquiry
BPG-1282-6 Biotin-PEG-Biotin, MW 10k In stock Inquiry
BPG-1282-7 Biotin-PEG-Biotin, MW 20k In stock Inquiry
BPG-1282-8 Biotin-PEG-Biotin, MW 35 In stock Inquiry
  • Product Information
  • Application
  • References
  • Documents
  • Reviews

Product Information

Description Biotin-PEG-Biotin has two activated terminal groups. Biotin groups are often used in labeling. Homobifunctionalized PEG derivatives have wide applications in peptides, proteins, lipids, other small molecules and surface modifications. Drug PEGylation can alter its dispersity and solubility in aqueous solutions. PEG modification can create a spatial barrier around the drug, reduce the enzymatic hydrolysis of the drug, avoid the rapid elimination of kidney metabolism, and allow the drug to be recognized by cells of the immune system.
Synonyms Biotin-PEG-Biotin; SCHEMBL15216220; Biotin-PEG-Biotin, MW 1,000; Biotin-PEG-Biotin, MW 2,000; Biotin-PEG-Biotin, MW 3,400; Biotin-PEG-Biotin, MW 5,000; Biotin-PEG-Biotin, MW 10,000; HY-140656A
IUPAC Name 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[2-[2-[2-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethoxy]ethoxy]ethyl]pentanamide
Canonical SMILES C1C2C(C(S1)CCCCC(=O)NCCOCCOCCNC(=O)CCCCC3C4C(CS3)NC(=O)N4)NC(=O)N2
InChI InChI=1S/C26H44N6O6S2/c33-21(7-3-1-5-19-23-17(15-39-19)29-25(35)31-23)27-9-11-37-13-14-38-12-10-28-22(34)8-4-2-6-20-24-18(16-40-20)30-26(36)32-24/h17-20,23-24H,1-16H2,(H,27,33)(H,28,34)(H2,29,31,35)(H2,30,32,36)/t17-,18-,19-,20-,23-,24-/m0/s1
InChIKey RFBDICOMYQOCQQ-IGJOJHROSA-N
Solubility Soluble in water, DMSO and DMF. Freshly prepared before use.
Storage -20°C for long-term preservation, keep in dry and avoid sunlight. Avoid repeated freezing and thawing.
References 1. Ichikawa, Musubu, et al. Improved crystal-growth and emission gain-narrowing of thiophene/phenylene co-oligomers. Advanced Materials, 2003, 15(3): 213-217.
2. Salem, Aliasger K., et al. Porous polymer and cell composites that self-assemble in situ. Advanced Materials, 2003, 15(3): 210-213.

Reviews

If you have any suggestions or comments about mPEG-Br, please submit a review immediately.

submit

Related Link

Why BOC Sciences?

  • Large Stock

    More than 2000+ products in inventory

  • Global Delivery

    Warehouses in multiple cities to ensure fast delivery

  • mg to kg

    Multi specification for academic research and industrial production

  • 24/7 Technical Support

    Strict process parameter control to ensure product quality

Products

Resources

Our Feature

BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.

  • Our Feature icon1
  • Our Feature icon2
  • Our Feature icon3
  • Our Feature icon4
PEGylation of Peptides and Proteins

PEGylation of Peptides
and Proteins

Reduce the Immunogenicity of Peptide/Protein Drugs

Learn More

APPLICATIONS

APPLICATIONS

PEG linkers For Drug

Improved Circulation Half-Life

Learn More

Have Customer Reviewed On Us?

logo

Chat With Us

Online Inquiry

Verification code

Copyright © 2024 BOC Sciences. All rights reserved.

Inquiry Basket